The presence of both CD4+ and CD8+ cells in the circulation of our healthy subjects capable of recognizing and proliferating in response to RV39 is consistent with the rapid (day 4 post infection) engagement of an adaptive immune response after experimental inoculation with this virus strain and as such, the engagement of a heterologous immune response. The gene discussed is CD4; the disease is infection.